AsCNP/JSNP/JSCNP 2019

セッション情報

[AsCNP] シンポジウム

AsCNP » [AsCNP] シンポジウム

[AsCNP_S19] シンポジウム19
Future Development of Biomarker in Mental disorders

2019年10月11日(金) 16:30 〜 18:10 第12会場 (503)

Organizer / Chair: Andi Jayalangkara TANRA (Department of Psychiatry, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia), Co-chair: Minoru TAKEBAYASHI (Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Japan), Discussant: ‌Kristian LIAURY (Department of Psychiatry, Hasanuddin University, Indonesia)

Currently, there is an increasing number of techniques developed for biomarker of mental disorders.
One of that is the sAA (Salivary Alpha Amylase) Enzyme, which is produced by parotic gland in oral cavity. This enzyme could predict the level of stress from patients such as Psychotic, Depression, Bipolar and Anxiety through SAM (Sympathetic Adreno Medullary) system. Measuring the level of this enzyme is easy, safe and non-invasive, nonetheless the result is still in controversy.
However, the trait marker represents the properties of biological processeson behavior which play antecedent and possiblythe pathophysiology role of mental disorder such as schizophrenia.
Therefore, serotonin transporter (SERT) system is still challenging to be explored as a biological marker of major depression, focused in animal model. Dysregulation of immune system is also closely involved in the pathogenesis of depression.
Finally, the glutamate decarboxylase like protein 1 (GADL1)variant could be used as a biomarker to predict therapeutic response to lithium maintenance treatment in bipolar l patients.
The 4 speakers will give contribution for elaborating future development of Biomarker for mental disorders and will enhance interesting discussion in our symposium.

16:30 〜 16:34

Andi Jayalangkara TANRA (Department of Psychiatry, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia)

17:20 〜 17:43

Akihiro MOURI1, Kazuo KUNISAWA1, 2, Hidetsugu FUJIGAKI3, Yasuko YAMAMOTO3, Kuniaki SAITO3, Toshitaka NABESHIMA2 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan, 2. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan, 3. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan)

18:06 〜 18:10

Minoru TAKEBAYASHI (Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Japan)